These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12528)
1. Effects of pyrroxan and chlordiazepoxide on biogenic amine metabolism in the rat brain. Pugsley TA; Lippmann W Psychopharmacology (Berl); 1976 Nov; 50(2):113-8. PubMed ID: 12528 [TBL] [Abstract][Full Text] [Related]
2. Effects of chlordiazepoxide administration on biogenic amines in cat brain. Vachon L; Roberge AG Can J Physiol Pharmacol; 1983 Jan; 61(1):81-8. PubMed ID: 6188521 [TBL] [Abstract][Full Text] [Related]
3. Piperidine: effects on locomotor activity and brain monoamine turnover. Alm B Psychopharmacology (Berl); 1976 Nov; 50(3):301-4. PubMed ID: 826977 [TBL] [Abstract][Full Text] [Related]
4. The effect of penfluridol and some psychotropic drugs on monoamine metabolism in central nervous system. Nose T; Takemoto H Eur J Pharmacol; 1975 Apr; 31(2):351-9. PubMed ID: 238856 [TBL] [Abstract][Full Text] [Related]
5. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines. Nakanishi M; Setoguchi M Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010 [No Abstract] [Full Text] [Related]
6. Effects of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo [3,4-c]thieno[2,3-e][1,4]diazepine (Y-7131) on the metabolism of biogenic amines in brain. Setoguchi M; Takehara S; Nakajima A; Tsumagari T; Takigawa Y Arzneimittelforschung; 1978; 28(7):1165-9. PubMed ID: 39571 [TBL] [Abstract][Full Text] [Related]
7. Effects of taclamine (AY-22,214), a new psychoactive agent, on catecholamine and serotonin metabolism. Pugsley TA; Lippmann W Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):73-87. PubMed ID: 1156020 [TBL] [Abstract][Full Text] [Related]
8. Effects of CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl] butyl]-2,-4-imidazolidinedione), an antihypertensive agent, on rat brain catecholamine and serotonin turnover. Pugsley TA; Myers SM; Shih YH J Cardiovasc Pharmacol; 1989 Mar; 13(3):455-64. PubMed ID: 2471893 [TBL] [Abstract][Full Text] [Related]
9. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate. Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223 [TBL] [Abstract][Full Text] [Related]
10. Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines. el-Etri MM; Nickell WT; Ennis M; Skau KA; Shipley MT Exp Neurol; 1992 Nov; 118(2):153-63. PubMed ID: 1426125 [TBL] [Abstract][Full Text] [Related]
11. Noradrenaline, dopamine, serotonin: different effects of psychological stress on brain biogenic amines in mice and rats. Konstandi M; Johnson E; Lang MA; Malamas M; Marselos M Pharmacol Res; 2000 Mar; 41(3):341-6. PubMed ID: 10675287 [TBL] [Abstract][Full Text] [Related]
12. Reuptake of biogenic amines by brain slices: effect of hydrocortisone. Lieberman KW; Stokes PE; Fanelli CJ; Klevan T Psychopharmacology (Berl); 1980; 70(1):59-61. PubMed ID: 6775336 [TBL] [Abstract][Full Text] [Related]
13. Chlordiazepoxide, go-nogo successive discrimination and brain biogenic amines in cats. Vachon L; Kitsikis A; Roberge AG Pharmacol Biochem Behav; 1984 Jan; 20(1):9-22. PubMed ID: 6198668 [TBL] [Abstract][Full Text] [Related]
14. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain. Petkov VD; Konstantinova E Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322 [TBL] [Abstract][Full Text] [Related]
15. Regulation of pyridoxal-5'-phosphate level by biogenic amines in mouse brain. Asakura T; Takahashi N; Hirakawa T; Ohkawa K; Hibi N Neurochem Res; 1996 Jan; 21(1):47-50. PubMed ID: 8833223 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain. Poddubiuk ZM; Kleinrok Z Psychopharmacology (Berl); 1976 Oct; 50(1):95-102. PubMed ID: 138146 [TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Griebel G; Curet O; Perrault G; Sanger DJ Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388 [TBL] [Abstract][Full Text] [Related]
18. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities. Lippman W; Pugsley TA Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878 [TBL] [Abstract][Full Text] [Related]
19. Changes in the turnover of monoamines in prefrontal cortex of rats fed on vitamin E-deficient diet. CastaƱo A; Venero JL; Cano J; Machado A J Neurochem; 1992 May; 58(5):1889-95. PubMed ID: 1560242 [TBL] [Abstract][Full Text] [Related]
20. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover. Pugsley TA; Lippmann W Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]